Sep 29

PQA 07 - PQA 07: Head and Neck Cancer, Lung Cancer/Thoracic Malignancies, and Nursing and Supportive Care

3652 - Phase II Trial of Tislelizumab plus Chemotherapy with Response-Adapted Radiotherapy for De Novo Metastatic Nasopharyngeal Carcinoma

03:45pm - 05:00pm ET

Presenter(s)

Chengchen Wang, MD - Department of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Cancer Hospital, Chongqing,